Home > Boards > US Listed > Biotechs > Alimera Sciences (ALIM)

ALIM News: Quarterly Report (10-q) 05/11/2017 09:13:51 AM

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mick Member Profile
Member Level 
Followed By 2,575
Posts 846,954
Boards Moderated 191
Alias Born 09/04/00
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/21/2019 4:17:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/20/2019 4:28:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/20/2019 4:27:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/20/2019 4:27:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/20/2019 4:27:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/20/2019 4:22:42 PM
Alimera’s ILUVIEN® Receives Positive NICE Recommendation for Non-Infectious Posterior Uveitis GlobeNewswire Inc. - 6/20/2019 8:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/20/2019 6:01:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2019 5:22:07 PM
Three-Year Clinical Trial Results Support ILUVIEN® Launch in Europe for the Prevention of Relapse in Recurrent Non-Infectiou... GlobeNewswire Inc. - 6/6/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2019 5:20:39 PM
Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educate Consumers on Diabeti... GlobeNewswire Inc. - 5/22/2019 8:00:00 AM
Alimera Sciences to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019 GlobeNewswire Inc. - 5/14/2019 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 4:37:04 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 4:43:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/1/2019 4:35:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/30/2019 8:10:25 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/29/2019 4:34:34 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2019 4:21:57 PM
Alimera Sciences Announces First Quarter 2019 Financial Results and Provides Corporate Overview GlobeNewswire Inc. - 4/29/2019 4:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2019 5:21:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/29/2019 4:48:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/1/2019 4:44:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2019 5:08:57 PM
Annual Report (10-k) Edgar (US Regulatory) - 2/25/2019 5:03:49 PM
mick Member Level  Wednesday, 05/24/17 07:34:57 AM
Re: None
Post # of 926 
ALIM News: Quarterly Report (10-q) 05/11/2017 09:13:51 AM
ALIM News: Current Report Filing (8-k) 05/09/2017 06:07:19 AM
ALIM News: Alimera Sciences Reports First Quarter 2017 Financial Results 05/08/2017 04:58:23 PM
ALIM News: Additional Proxy Soliciting Materials (definitive) (defa14a) 05/03/2017 04:41:49 PM
ALIM News: Revised Proxy Soliciting Materials (definitive) (defr14a) 05/03/2017 04:37:29 PM


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist